| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.28 | 5e-09 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.2 | 9e-09 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.22 | 4e-06 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-06 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.25 | 8e-06 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |